Kyto Technology and Life Science Inc
OTC:KBPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kyto Technology and Life Science Inc
Total Receivables
Kyto Technology and Life Science Inc
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kyto Technology and Life Science Inc
OTC:KBPH
|
Total Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ameriprise Financial Inc
NYSE:AMP
|
Total Receivables
$15B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
KKR & Co Inc
NYSE:KKR
|
Total Receivables
$691.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
BlackRock Inc
NYSE:BLK
|
Total Receivables
$5.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
Bank of New York Mellon Corp
NYSE:BK
|
Total Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Blackstone Inc
NYSE:BX
|
Total Receivables
$6.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
Kyto Technology and Life Science Inc
Glance View
Kyto Technology & Life Science, Inc. is focused on the development of early stage technology and life science businesses through early stage investment funding. The company is headquartered in Los Altos Hills, California. The company went IPO on 2004-08-02. The firm operates as a mentor, advisor, external manager and investor for selected privately held companies in the United States of America, Canada and Israel. The Company’s portfolio includes CNote Group, Inc. (CNote), Achelios Therapeutics, Inc. (Achelios), Seal Rock Therapeutics, Inc., SageMedic, Corp, Sanaby Sciences Acquisition Corp., LLC, Rhaeos, Inc., Polymertal Ltd., PreView Medical, Inc, Avisi Technologies Inc., Astrocyte Pharmaceuticals Inc., AOA Inc., Basepaws, Inc., Boardwalktech, Inc., CNote Group, Inc., CoLabs, Inc., Deep Blue Medical Advances, Inc., EuMentis Therapeutics Inc., Everykey Inc, FemtoDx, Inc., iDentical, Inc., i-Lumen Scientific, Inc., inBay Technologies Inc., Inhalon Biopharma Inc., IRIS R&D Group Inc., Kiana Analytics, Inc., and Light Line Medical, Inc.
